The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. 2026 FDA Peptide Reclassification Purefico Medspa and Therapy